DonaldBerrySandersMD
Internal Medicine • Mobile, ALHospice & Palliative Medicine, Hospital Medicine/Hospitalist, Preventive Medicine
Medical Director of Springhill Senior Residence Medical Director of Knollwood health care and Rehabilitation Partner at Alabama Medical Group
Dr. Sanders is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Memorial Hospital Dr
suite200
Mobile, AL 36608Phone+1 251-414-5900Fax+1 251-281-1264
Summary
- Dr. Donald Sanders, MD is an internal medicine specialist based in Mobile, AL with subspecialties in hospice & palliative medicine, hospital medicine, and preventive medicine. His education includes a residency in internal medicine at the Physicians Medical Center Carraway and a degree from the University of Alabama School of Medicine in 1989. Dr. Sanders is a prolific author, with several publications cited by peers in the field multiple times, focusing mainly on neuromuscular disorders such as myasthenia gravis. He has been involved in clinical trials aimed at developing treatments for myasthenia gravis. In 2012, Dr. Sanders was awarded Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services.
Education & Training
Physicians Medical Center CarrawayResidency, Internal Medicine, 1989 - 1992
University of Alabama School of MedicineClass of 1989
Certifications & Licensure
AL State Medical License 1990 - 2025- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Mycophenolate Mofetil in Myasthenia Gravis Start of enrollment: 2002 Sep 01
- Efficacy of Prednisone In the Treatment of Ocular Myasthenia Start of enrollment: 2011 Dec 01
- Disease-Modifying Treatments for Myasthenia Gravis Start of enrollment: 2018 May 07
Publications & Presentations
PubMed
- 12 citationsDoes change in neuromuscular Jitter predict or correlate with clinical change in mgDonald B. Sanders, Janice M. Massey
Muscle & Nerve. 2017-07-01 - 38 citationsFactors affecting outcome in myasthenia gravis.J. B. Andersen, Nils Erik Gilhus, Donald B. Sanders
Muscle & Nerve. 2016-12-01 - 87 citationsInternational clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.Ted M. Burns, Reza Sadjadi, Kimiaki Utsugisawa, Kelly G. Gwathmey, Amruta Joshi
Muscle & Nerve. 2016-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
